These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34895001)

  • 1. Fructose and biotin co-modified liposomes for dual-targeting breast cancer.
    Li R; Peng Y; Pu Y; Zhao Y; Nie R; Guo L; Wu Y
    J Liposome Res; 2022 Jun; 32(2):119-128. PubMed ID: 34895001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, preparation and evaluation of different branched biotin modified liposomes for targeting breast cancer.
    Tang B; Peng Y; Yue Q; Pu Y; Li R; Zhao Y; Hai L; Guo L; Wu Y
    Eur J Med Chem; 2020 May; 193():112204. PubMed ID: 32172035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-targeting liposomes with active recognition of GLUT
    Pu Y; Zhang H; Peng Y; Fu Q; Yue Q; Zhao Y; Guo L; Wu Y
    Eur J Med Chem; 2019 Dec; 183():111720. PubMed ID: 31553933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomes modified with double-branched biotin: A novel and effective way to promote breast cancer targeting.
    Lu R; Zhou L; Yue Q; Liu Q; Cai X; Xiao W; Hai L; Guo L; Wu Y
    Bioorg Med Chem; 2019 Jul; 27(14):3115-3127. PubMed ID: 31155297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotin and glucose dual-targeting, ligand-modified liposomes promote breast tumor-specific drug delivery.
    Huang M; Pu Y; Peng Y; Fu Q; Guo L; Wu Y; Zheng Y
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127151. PubMed ID: 32317211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotin and glucose co-modified multi-targeting liposomes for efficient delivery of chemotherapeutics for the treatment of glioma.
    Liu Q; Zhou L; Lu R; Yang C; Wang S; Hai L; Wu Y
    Bioorg Med Chem; 2021 Jan; 29():115852. PubMed ID: 33189509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple branched RGD modification on liposomes: A prospective strategy to enhance the glioma targeting efficiency.
    Li Z; Lu J; Tang B; Shi Y; Hai L; Guo L; Wu Y
    Bioorg Med Chem; 2022 Apr; 60():116704. PubMed ID: 35286953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-targeting liposome modified by glutamic hexapeptide and folic acid for bone metastatic breast cancer.
    Yang Y; Zhao Z; Xie C; Zhao Y
    Chem Phys Lipids; 2020 May; 228():104882. PubMed ID: 32017901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual Receptor Targeting Cell Penetrating Peptide Modified Liposome for Glioma and Breast Cancer Postoperative Recurrence Therapy.
    Qiu Y; Yu Q; Liu Y; Tang J; Wang X; Lu Z; Xu Z; He Q
    Pharm Res; 2018 Apr; 35(7):130. PubMed ID: 29700620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Size-adaptable and ligand (biotin)-sheddable nanocarriers equipped with avidin scavenging technology for deep tumor penetration and reduced toxicity.
    Jin Y; Wu Z; Wu C; Zi Y; Chu X; Liu J; Zhang W
    J Control Release; 2020 Apr; 320():142-158. PubMed ID: 31978442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-active targeting liposomes drug delivery system for bone metastatic breast cancer: Synthesis and biological evaluation.
    Zhao Z; Zhao Y; Xie C; Chen C; Lin D; Wang S; Lin D; Cui X; Guo Z; Zhou J
    Chem Phys Lipids; 2019 Sep; 223():104785. PubMed ID: 31194968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-targeting for brain-specific liposomes drug delivery system: Synthesis and preliminary evaluation.
    Peng Y; Zhao Y; Chen Y; Yang Z; Zhang L; Xiao W; Yang J; Guo L; Wu Y
    Bioorg Med Chem; 2018 Sep; 26(16):4677-4686. PubMed ID: 30098913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Tumor Penetration of Paclitaxel Loaded pH Sensitive Cleavable Liposomes by Depletion of Tumor Collagen I in Breast Cancer.
    Zhang L; Wang Y; Yang Y; Liu Y; Ruan S; Zhang Q; Tai X; Chen J; Xia T; Qiu Y; Gao H; He Q
    ACS Appl Mater Interfaces; 2015 May; 7(18):9691-701. PubMed ID: 25845545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antilung cancer effect of ergosterol and cisplatin-loaded liposomes modified with cyclic arginine-glycine-aspartic acid and octa-arginine peptides.
    Wu M; Huang T; Wang J; Chen P; Mi W; Ying Y; Wang H; Zhao D; Huang S
    Medicine (Baltimore); 2018 Aug; 97(33):e11916. PubMed ID: 30113492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymeric liposomes targeting dual transporters for highly efficient oral delivery of paclitaxel.
    Xing Y; Lian X; Zhang Y; Zhang Y; Guo X
    Carbohydr Polym; 2024 Jun; 334():121989. PubMed ID: 38553209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides.
    Sun J; Jiang L; Lin Y; Gerhard EM; Jiang X; Li L; Yang J; Gu Z
    Int J Nanomedicine; 2017; 12():1517-1537. PubMed ID: 28280323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyroservatide-TPGS-paclitaxel liposomes: Tyroservatide as a targeting ligand for improving breast cancer treatment.
    Jin X; Li M; Yin L; Zhou J; Zhang Z; Lv H
    Nanomedicine; 2017 Apr; 13(3):1105-1115. PubMed ID: 27845234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic tumor microenvironment targeting and blood-brain barrier penetration via a pH-responsive dual-ligand strategy for enhanced breast cancer and brain metastasis therapy.
    Li M; Shi K; Tang X; Wei J; Cun X; Long Y; Zhang Z; He Q
    Nanomedicine; 2018 Aug; 14(6):1833-1843. PubMed ID: 29800759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two methods for tumour-targeting peptide modification of liposomes.
    Huang SQ; Zhang HM; Zhang YC; Wang LY; Zhang ZR; Zhang L
    Acta Pharmacol Sin; 2023 Apr; 44(4):832-840. PubMed ID: 36271156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.